Giuseppe Lopalco

University of Bari

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (10)

P Delvino

University of Pavia

Pasquale Stefanizzi

Donato Rigante

Assistant Professor

Università Cattolica del Sacro Cuore

Luca Cantarini

Associate Professor of Rheumatology

University of Siena

Claudia Fiorillo

Associate Professor in Clinical Biochemistry

University of Florence

Marco Fornaro

University of Bari Aldo Moro

silvio tafuri

Assistant Professor

Università degli Studi di Bari

Florenzo Iannone

Maurizio Rossini

Director/Prof

University of Verona

Marco Sebastiani

University of Modena and Reggio Emilia

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giuseppe Lopalco

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (10)

P Delvino

Pasquale Stefanizzi

Donato Rigante

Luca Cantarini

Claudia Fiorillo

Marco Fornaro

silvio tafuri

Florenzo Iannone

Maurizio Rossini

Marco Sebastiani

Make your next move.

Giuseppe Lopalco

Research Interests

Explore related searches

Contact this professor

Articles (20)

Eyes on fire: a diagnostic and therapeutic dilemma

Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib

Targeting Janus kinase 1 in refractory Behçet’s disease: a case report on the clinical efficacy of upadacitinib

Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study

Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry

Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity

Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors

Exploring relief for Behçet’s disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilast

Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study

From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”

Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis

Uncovering the Underworld of Axial Spondyloarthritis

Beyond the horizon: Innovations and future directions in axial-spondyloarthritis

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection

A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study

The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment

Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients

Safety of systemic treatments for Behçet’s syndrome

Collaborators (10)

P Delvino

Pasquale Stefanizzi

Donato Rigante

Luca Cantarini

Claudia Fiorillo

Marco Fornaro

silvio tafuri

Florenzo Iannone

Maurizio Rossini

Marco Sebastiani

Make your next move.